semaglutide step Change in body weight with 2.4 mg: trials [95–98] Design and Baseline Characteristics of
Description
Semaglutide commonly causes nausea, constipation, and appetite changes initially, typically resolving within weeks as the body adapts
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](http://www.jacc.org/cms/asset/8da476a3-c61b-4e0b-a537-2d1859d4a7e4/ga1.jpg)
It makes constipation harder to resolve, increases the concentration of bile acids that irritate the gut lining, reduces the volume of protective mucus, and impairs the motility that probiotics are trying to support
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](https://images.ctfassets.net/jj2wf7627pjc/4pj2Sh8yqKC9y2bx4SpBd/72112af4e82edb55faf86b34f6fbc9f8/semaglutide-dosage-chart-ro-m__1_.png)
Try switching to a different site for several weeks to see if the reactions resolve
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](https://www.thelancet.com/cms/10.1016/S2213-8587(25)00226-8/asset/fd74d5b9-b94f-420a-ba3e-9f0baf1be2f1/main.assets/gr2_lrg.jpg)
If youve stopped using a GLP-1 medication: This is where things get really interesting
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](https://images-eureka.patsnap.com/patent_img/7f6bcec5-229d-443d-b6d7-4248b97c718b/HDA0002871784060000011.png)
While it is approved across the US, UK, and EU, make sure to check these two parameters in your region before placing an order
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](https://framerusercontent.com/images/hg9PkIcYTFR6hdRX5rYMxIRUXZw.png)
Progress Analytics Beautiful, easy-to-read charts show your weight loss trajectory, weekly nutrition trends, medication responses, and wellbeing scores over time turning raw data into genuine insights
![semaglutide step Change in body weight with 2.4 mg: trials [9598] Design and Baseline Characteristics of](https://cdn.shopify.com/s/files/1/0681/6887/6288/files/preparing-semaglutide-pen-for-injection.webp?v=1749579396)